Genetec Technology Berhad Statistics
Total Valuation
KLSE:GENETEC has a market cap or net worth of MYR 220.34 million. The enterprise value is 245.45 million.
Important Dates
The next estimated earnings date is Wednesday, November 25, 2026.
| Earnings Date | Nov 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:GENETEC has 773.12 million shares outstanding. The number of shares has increased by 0.37% in one year.
| Current Share Class | 773.12M |
| Shares Outstanding | 773.12M |
| Shares Change (YoY) | +0.37% |
| Shares Change (QoQ) | +5.45% |
| Owned by Insiders (%) | 32.95% |
| Owned by Institutions (%) | 10.20% |
| Float | 476.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.13 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | 11.44 |
| P/OCF Ratio | 5.32 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 12.74 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.28 |
| Quick Ratio | 2.19 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.94 |
| Interest Coverage | -22.09 |
Financial Efficiency
Return on equity (ROE) is -30.15% and return on invested capital (ROIC) is -29.75%.
| Return on Equity (ROE) | -30.15% |
| Return on Assets (ROA) | -13.54% |
| Return on Invested Capital (ROIC) | -29.75% |
| Return on Capital Employed (ROCE) | -34.04% |
| Weighted Average Cost of Capital (WACC) | 8.60% |
| Revenue Per Employee | 285,555 |
| Profits Per Employee | -282,207 |
| Employee Count | 362 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 14.32 |
Taxes
In the past 12 months, KLSE:GENETEC has paid 240,000 in taxes.
| Income Tax | 240,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.64% in the last 52 weeks. The beta is 1.04, so KLSE:GENETEC's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -13.64% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 51.25 |
| Average Volume (20 Days) | 2,008,730 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:GENETEC had revenue of MYR 103.37 million and -102.16 million in losses. Loss per share was -0.13.
| Revenue | 103.37M |
| Gross Profit | -73.58M |
| Operating Income | -98.22M |
| Pretax Income | -101.92M |
| Net Income | -102.16M |
| EBITDA | -94.20M |
| EBIT | -98.22M |
| Loss Per Share | -0.13 |
Full Income Statement Balance Sheet
The company has 50.44 million in cash and 75.81 million in debt, with a net cash position of -25.37 million or -0.03 per share.
| Cash & Cash Equivalents | 50.44M |
| Total Debt | 75.81M |
| Net Cash | -25.37M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 287.49M |
| Book Value Per Share | 0.35 |
| Working Capital | 121.94M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 41.41 million and capital expenditures -22.15 million, giving a free cash flow of 19.26 million.
| Operating Cash Flow | 41.41M |
| Capital Expenditures | -22.15M |
| Depreciation & Amortization | 4.02M |
| Net Borrowing | -9.70M |
| Free Cash Flow | 19.26M |
| FCF Per Share | 0.02 |
Full Cash Flow Statement Margins
Gross margin is -71.18%, with operating and profit margins of -95.02% and -98.83%.
| Gross Margin | -71.18% |
| Operating Margin | -95.02% |
| Pretax Margin | -98.60% |
| Profit Margin | -98.83% |
| EBITDA Margin | -91.13% |
| EBIT Margin | -95.02% |
| FCF Margin | 18.63% |
Dividends & Yields
KLSE:GENETEC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.37% |
| Shareholder Yield | -0.37% |
| Earnings Yield | -45.67% |
| FCF Yield | 8.74% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on January 7, 2022. It was a forward split with a ratio of 13.
| Last Split Date | Jan 7, 2022 |
| Split Type | Forward |
| Split Ratio | 13 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |